UNSPSC 51143712: Niacin/pentylenetetrazol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143712 Niacin/pentylenetetrazol is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems—falls outside the pharmaceutical ingredient scope of the code's nominal category. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through a competitive bidding process with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. This procurement targets finished pharmaceutical products and medical devices for emergency opioid response and harm reduction, not the specialty chemicals the code purports to classify. The mismatch suggests either a data-entry error in the opportunity's UNSPSC tagging or that the code sees minimal genuine activity in state and local markets.

The source provides no additional recent opportunities under UNSPSC 51143712 to characterize issuing-body mix, geographic spread, or representative solicitation patterns. The single Seminole County record indicates county-level health purchasing but does not support a broader profile of activity or repeat buyers across state or local jurisdictions. Practitioners considering this code should verify the accuracy of opportunity tagging before allocating pursuit resources.